The briefing
A Nature study identifies tRNA1Arg(UCU) as a regulator of lineage transitions in prostate cancer that influence resistance to androgen receptor–targeted therapies. Modulating this tRNA affects a SWI/SNF‑centered translational program and correlates with metastasis and poor survival, suggesting a potential therapeutic avenue.
Original headline
tRNA dosage regulates lineage dependency and resistance in prostate cancer